Clonidine-sufentanil versus remifentanil in endoscopic sinus surgery

Phase 4

Completed

• Conditions: Quality of surgical field in term of bleeding in endoscopic sinus surgery; Anaesthesiology - Anaesthetics; Surgery - Other surgery

• Registration Number: ACTRN12614000935639
• Lead Sponsor: aurent Bairy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-09-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

Patients undergoing elective endoscopic sinus procedures with ASA score I to III.

Exclusion Criteria

Cardiac disorders other than supraventricular tachycardia
Cerebrovascular disorder
Renal or hepatic disorder
Non treated arterial hypertension
Beta blocking agent therapy
Platelet inhibiting agent or anticoagulant therapy
Coagulopathy
Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fromme score (0-5).[15 min after beginning and at the end of the surgery.]

Secondary Outcome Measures

Name	Time	Method
Heartrate (measured by ECG and pulse oximeter) and Blood pressure (measured by an automated oscillometric device)<br>[Heartrate is monitored continuously during surgery and the recovery room stay. Blood pressure is taken every 3 minutes during the surgery and every 10 minutes in the recovery room.];Time to eyes opening.[At the end of the surgery.];Time spent in the recovery room.[When the patient leaves the recovery room.];Pain scores (VAS).[During the recovery room stay.];Occurrence of adverse events in recovery (hypotension, bradycardia, nausea and vomiting).[During the recovery stay.];Amount of Piritramide received by the patient (The source of this information is the institutional computerized prescription system).[When the patient leaves the recovery room.]